When.com Web Search

  1. Ads

    related to: e coli uti treatment guidelines idsa

Search results

  1. Results From The WOW.Com Content Network
  2. Urinary anti-infective agent - Wikipedia

    en.wikipedia.org/wiki/Urinary_anti-infective_agent

    Within the penicillin class, pivmecillinam is considered the first-line empiric treatment for acute cystitis due to its wide spectrum of activity against gram-negative bacteria and its specific efficacy in the urinary tract. It has consistently demonstrated a high cure rate of over 85% for UTIs and a low resistance rate among E. coli strains.

  3. Infectious Diseases Society of America - Wikipedia

    en.wikipedia.org/wiki/Infectious_Diseases...

    As of 2018, IDSA had more than 11,000 members from across the United States and nearly 100 other countries on six different continents. [2] IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

  4. Urinary tract infection - Wikipedia

    en.wikipedia.org/wiki/Urinary_tract_infection

    A urinary tract infection (UTI) is an infection that affects a part of the urinary tract. [1] Lower urinary tract infections may involve the bladder ( cystitis ) or urethra ( urethritis ) while upper urinary tract infections affect the kidney ( pyelonephritis ). [ 10 ]

  5. Pathogenic Escherichia coli - Wikipedia

    en.wikipedia.org/wiki/Pathogenic_Escherichia_coli

    Uropathogenic E. coli (UPEC) is responsible for approximately 90% of urinary tract infections (UTI) seen in individuals with ordinary anatomy. [11] In ascending infections, fecal bacteria colonize the urethra and spread up the urinary tract to the bladder as well as to the kidneys (causing pyelonephritis), [37] or the prostate in males. Because ...

  6. Uromune - Wikipedia

    en.wikipedia.org/wiki/Uromune

    Uromune, also known by its developmental code name MV-140, is a polyvalent bacterial vaccine which is used and is being developed for prevention of recurrent urinary tract infections (UTIs). [ 1 ] [ 2 ] [ 3 ] In clinical studies , it has been found to reduce total number of UTIs by about 70%, to increase UTI-free rates from around 25% to 57% ...

  7. Enterobacter cloacae - Wikipedia

    en.wikipedia.org/wiki/Enterobacter_cloacae

    Some strains have been associated with urinary tract and respiratory tract infections in immunocompromised individuals. It is a high risk AmpC producer and treatment with cefepime is recommended by the IDSA if causing disease rather than simply colonising. [10] Treatment using cefepime and gentamicin has been reported. [11]